Clinical Trial Update: A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bicalutamide plus finasteride for MRI-detectable prostate nodules in men on active surveillance has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FINASTERIDE (FINASTERIDE)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Detectable Prostate Nodules | Phase 2 | Status: WITHDRAWN